First Trust Advisors LP Cullinan Oncology, Inc. Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$15.63 - $29.35 $642,643 - $1.21 Million
41,116 Added 42.93%
136,887 $2.39 Million
Q1 2024

May 13, 2024
BUY
$10.17 - $19.02 $29,452 - $55,081
2,896 Added 3.12%
95,771 $1.63 Million
Q4 2023

Feb 13, 2024
BUY
$7.89 - $10.23 $18,186 - $23,580
2,305 Added 2.54%
92,875 $946,000
Q3 2023

Nov 13, 2023
BUY
$9.05 - $11.72 $819,658 - $1.06 Million
90,570 New
90,570 $819,000

Others Institutions Holding CGEM

# of Institutions
146
Shares Held
67.6M
Call Options Held
612K
Put Options Held
118K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $499M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email